2022 Infectious Disease: Ending the HIV Epidemic with PrEP [IFD22-8581]
December 13, 2021
December 31, 2022
Question Expiration Policy
Each question may be answered for 48 hours after the question is delivered
The "Ending the HIV Epidemic with PrEP in 2022" course will enhance medical knowledge about and increase prescribing of pre-exposure prophylaxis to prevent HIV as part of the Practice Transformation project of the Southeast AETC. This 18 question quiz will provide up to 3.5 AMA PRA Category 1 Credits™. This quiz is aimed at providers that are currently prescribing PrEP in primary care or other locations not specializing in infectious disease, initially at sites involved in the Southeast AETC Practice Transformation project.
This course, powered by QuizTime, consists of 18 questions delivered once per weekday so it will take approximately 4 weeks to complete. Each question allows for 1 reattempt if your first attempt is not correct, and each question expires 48 hours after it is sent. Before the conclusion of the course, you will receive an email containing any questions you have not attempted, and you will have 48 hours from the time the email is sent as a last chance for answering those questions. Upon completion of this course, you will receive a numeric credit code and instructions for texting that to our credit system to claim your credits.
Vanderbilt University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vanderbilt University Medical Center designates this enduring material for a maximum of 3.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Course Director: Cody Chastain, MD
Course Item Writers: Cody Chastain, MD and Sean Kelly, MD
Course Reviewers: Kim V. Garvey, MLIS, MS, PhD and Rob Bland, BA, MS
CME Activity Director: Bonnie Miller, MD, MMHC
CME Activity Coordinator: Emily Lagunas
Faculty indicated they have no financial relationships related to the content of this activity to disclose.
At the end of this QuizTime learning activity, the learner will be able to:
Describe the efficacy of pre-exposure prophylaxis (PrEP) for preventing HIV
Identify risk factors for HIV acquisition and persons who may benefit from PrEP
Recommend and interpret appropriate diagnostic testing prior to initiating and during monitoring of PrEP
Recommend appropriate vaccinations for infectious disease prevention pertinent to sexual health
Select appropriate medications for PrEP in the context of clinical scenarios
3.5 AMA PRA Category 1 CreditsTM will be awarded if the quiz taker attempts 14 or more of the 18 questions with the intent for each question to be answered correctly within two allowed attempts.
AMA PRA Category 1 Credits™: 3.50 credits awarded for answering at least 14 questions .
Non-Physician Attendance: 3.50 credits awarded for answering at least 14 questions .